Jyothy Labs Limited (532926) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Jyothy Labs Limited ₹147, price ₹183, upside -19.4%, quality 61 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ₹123.13 – ₹562.71 · fair‑value band ₹89.51 – ₹213.37 · the ₹183.05 price screens above the ₹147.46 fair value. Dashed = 300-day average. As of Sep 24, 2026.
Jyothy Labs Limited, together with its subsidiaries, manufactures and markets detergents, soaps, and mosquito repellents in India and internationally. It operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, Laundry Services, and Others segments.
Show more
Jyothy Labs Limited, together with its subsidiaries, manufactures and markets detergents, soaps, and mosquito repellents in India and internationally. It operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, Laundry Services, and Others segments. The Dishwashing segment offers dish wash scrubbers and scrubber steel, as well as dish wash bars, liquids, and powders under the Pril and Exo brands. The Fabric Care segment provides fabric whiteners, fabric enhancers, bar soaps, and detergent powders under the Henko, Mr. White, Ujala, More light, and New Super Chek brands. The Household Insecticides segment offers mosquito repellent coils, liquids, and cards, as well as insect repellents and air care products under the Maya, Exo Floor Shine, and Maxo brands. The Personal Care segment provides body soaps, face washes, toothpastes, deodorants, talcum powders, after shave products, and moisturizers under the Margo, Fa, and Neem Active Toothpaste brands. The Laundry Services segment provides dry cleaning and laundry services under the Fabric Spa, Wardrobe, Four Seasons, Expert, Snoways, and Clickwash brands. The Others segment offers incense sticks and floor shine products. The company was formerly known as Jyothy Laboratories Limited and changed its name to Jyothy Labs Limited in July 2019. The company was founded in 1983 and is based in Mumbai, India.
Stock analysis
Jyothy Labs Limited (532926) currently trades at ₹183.05, while our model-based Fair Value estimate is ₹147.46, 19.4% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹171.49 per share, and 4 of the 26 models we run sit above the ₹183.05 price.
Bear case: the Asset-Based group reads lowest at ₹37.39, and 22 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: ₹89.51 (bear) to ₹213.37 (bull), the price of ₹183.05 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 61/100 (solid quality), in the Consumer Goods sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Jyothy Labs Limited reported revenue of ₹28.5B in FY2025 versus ₹19.1B in FY2021, a compound +10.5%/yr. Reported net income was ₹3.7B in FY2025, compounding +16.7%/yr from FY2021.
Key figures
Market cap ₹67.2B (≈ $698M) · P/E ratio 25.9 · P/S ratio 3.37 · EPS (TTM) ₹5.19 · Dividend yield 3.3% · Net margin 13.0% · Return on equity 14.1% · Return on assets (EBIT) 13.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 42% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Goods peers we cover trades at −30% fair-value upside, at −19%, 532926 screens cheaper than that median.
Fair Value models
Bear ₹89.51Fair Value ₹147.46Bull ₹213.37
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.92/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+3.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.7%
Start year 2020 (pandemic). Over 10 years: +6.6% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in INR (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+20.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+17.1%
Dividend (yield on the price)3.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11% → 15%
2025 sits 55% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Jyothy Labs Limited (532926) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹147.46 versus a price of ₹183.05, about −19% upside (overvalued).
What is the fair value of 532926?
Our model-based fair value for Jyothy Labs Limited is ₹147.46 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹183.05.
What is the quality score of 532926?
Jyothy Labs Limited has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Jyothy Labs Limited (532926)?
Our model-based price target is the fair value of ₹147.46 (as of Sep 24, 2026) from 26 valuation models. Cautious scenario ₹89.51, optimistic scenario ₹213.37. It is a calculation from audited fundamentals, not an analyst target.
What is the Jyothy Labs Limited stock forecast for 2026?
Our models put fair value at ₹147.46, about −19% upside versus a price of ₹183.05 (overvalued). Cautious scenario ₹89.51, optimistic scenario ₹213.37. The calculation is refreshed regularly with new filings.
What is the revenue of Jyothy Labs Limited (532926)?
Jyothy Labs Limited reported trailing-twelve-month revenue of about ₹17.5B (latest available figure, as of Sep 24, 2026).
Does Jyothy Labs Limited pay a dividend?
Jyothy Labs Limited currently shows a dividend yield of about 3.28% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Jyothy Labs Limited (532926)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Jyothy Labs Limited it is ₹147.46 per share (as of Sep 24, 2026), against a price of ₹183.05. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Jyothy Labs Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 532926 trades above its calculated fair value: price ₹183.05, fair value ₹147.46, a gap of about −19% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 532926?
No. The price is what the market pays today (₹183.05); the fair value is what the company's own numbers justify (₹147.46). For Jyothy Labs Limited the two are ₹35.59 per share apart. That gap is exactly why we show both numbers side by side.
How much is Jyothy Labs Limited worth?
The market values Jyothy Labs Limited at about ₹67.2B (market capitalisation, as of Sep 24, 2026). Per share that is ₹183.05; our models calculate a fair value of ₹147.46 per share.
What do the bullish and bearish scenarios say about 532926?
Our models span a range for Jyothy Labs Limited: cautious scenario ₹89.51, base ₹147.46, optimistic ₹213.37 per share (as of Sep 24, 2026, price ₹183.05). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is 532926 from its 52-week high?
Jyothy Labs Limited trades at ₹183.05, about 42% below its 52-week high of ₹315.26 and at the low of ₹183.05 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹147.46 is for.
Which stocks are comparable to Jyothy Labs Limited?
From the same area (Consumer Goods) we also value Ador Multiproducts Limited, HALDYNGL, TRITONV, Saint-Gobain Sekurit India Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Jyothy Labs Limited stock attractive at the current price?
The data as of Sep 24, 2026: price ₹183.05, calculated fair value ₹147.46 (−19%), Quality Score 61/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 532926 calculated?
We run Jyothy Labs Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹147.46, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Jyothy Labs Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Jyothy Labs Limited (532926)?
The closing price on Oct 1, 2026 was ₹183.05. Our model-based fair value is ₹147.46, about −19% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Jyothy Labs Limited right now?
Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹89.51 to ₹213.37) leaves room in how you read the outcome.
Key figures of Jyothy Labs Limited
How large is the market capitalisation of Jyothy Labs Limited (532926)?
The market capitalisation of Jyothy Labs Limited is ₹67.2B (≈ $698M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of Jyothy Labs Limited (532926)?
The price-to-earnings ratio of Jyothy Labs Limited is 25.9 (as of Aug 2, 2026). Price to earnings: how many years of current profit you pay for the stock. A P/E of 10 means ten years of profit.
What is the P/S ratio of Jyothy Labs Limited (532926)?
The price-to-sales ratio of Jyothy Labs Limited is 3.37 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Jyothy Labs Limited (532926)?
Earnings per share at Jyothy Labs Limited are ₹5.19 (price ÷ EPS = P/E 25.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Jyothy Labs Limited (532926)?
The dividend yield of Jyothy Labs Limited is 3.3% (payout 116%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Jyothy Labs Limited (532926)?
The net margin of Jyothy Labs Limited is 13.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Jyothy Labs Limited (532926)?
The return on equity (ROE) of Jyothy Labs Limited is 14.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Jyothy Labs Limited (532926)?
On an EBIT basis the return on assets of Jyothy Labs Limited is 13.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Jyothy Labs Limited (532926)?
The operating margin of Jyothy Labs Limited is 13.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Jyothy Labs Limited (532926)?
Revenue at Jyothy Labs Limited is growing +6.2% versus a year earlier (3y avg +9.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Jyothy Labs Limited (532926)?
Earnings per share at Jyothy Labs Limited are growing +11.8% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Continue in the live analysis
Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.
